Ameriprise’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.02M | Buy |
345,055
+240,945
| +231% | +$4.2M | ﹤0.01% | 2217 |
|
|
2025
Q1 | $1.31M | Buy |
104,110
+34,734
| +50% | +$437K | ﹤0.01% | 3072 |
|
|
2024
Q4 | $732K | Buy |
69,376
+36,928
| +114% | +$390K | ﹤0.01% | 3354 |
|
|
2024
Q3 | $470K | Buy |
+32,448
| New | +$470K | ﹤0.01% | 3491 |
|
|
2024
Q2 | – | Sell |
-34,570
| Closed | -$353K | – | 3936 |
|
|
2024
Q1 | $353K | Sell |
34,570
-41,720
| -55% | -$426K | ﹤0.01% | 3537 |
|
|
2023
Q4 | $418K | Sell |
76,290
-78,221
| -51% | -$429K | ﹤0.01% | 3515 |
|
|
2023
Q3 | $584K | Sell |
154,511
-121,675
| -44% | -$460K | ﹤0.01% | 3349 |
|
|
2023
Q2 | $1.85M | Sell |
276,186
-4,143
| -1% | -$27.8K | ﹤0.01% | 2915 |
|
|
2023
Q1 | $1.82M | Buy |
280,329
+244,919
| +692% | +$1.59M | ﹤0.01% | 2888 |
|
|
2022
Q4 | $302K | Sell |
35,410
-1,885
| -5% | -$16.1K | ﹤0.01% | 3581 |
|
|
2022
Q3 | $197K | Buy |
+37,295
| New | +$197K | ﹤0.01% | 3708 |
|
|
2021
Q3 | – | Sell |
-448,294
| Closed | -$13.8M | – | 3945 |
|
|
2021
Q2 | $13.8M | Buy |
448,294
+22,797
| +5% | +$704K | ﹤0.01% | 1649 |
|
|
2021
Q1 | $18.6M | Sell |
425,497
-3,217
| -0.8% | -$140K | 0.01% | 1376 |
|
|
2020
Q4 | $19.8M | Buy |
+428,714
| New | +$19.8M | 0.01% | 1232 |
|